Home > Financial Ratios > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Core EBITDA Margin

    Back to All Ratios
KILITCH DRUGS (INDIA) is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for KILITCH DRUGS (INDIA)
Please provide your vote to see the results

KILITCH DRUGS (INDIA) Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Margin(%) 15.7212.709.197.74-0.01

What is the latest Core EBITDA Margin ratio of KILITCH DRUGS (INDIA) ?

The latest Core EBITDA Margin ratio of KILITCH DRUGS (INDIA) is 15.72 based on Mar2024 Consolidated results.
Year Core EBITDA Margin
Mar202415.72
Mar202312.70
Mar20229.19
Mar20217.74
Mar2020-0.01

How is Core EBITDA Margin of KILITCH DRUGS (INDIA) Trending?

Years Core EBITDA Margin % Change
Mar2024 15.72
23.78
Mar2023 12.7
38.19
Mar2022 9.19
18.73
Mar2021 7.74
Positive
Mar2020 -0.01 -

Other Financial Ratios of KILITCH DRUGS (INDIA)


Compare Core EBITDA Margin ratio of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹492.7 Cr -0.7% -6% -12.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,246.0 Cr 4.7% -5.4% 0.5% Stock Analytics
DIVIS LABORATORIES ₹147,119.0 Cr 0.5% -9.8% 55.5% Stock Analytics
CIPLA ₹116,805.0 Cr 2% -1.8% -1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹103,554.0 Cr 2.6% -6.1% 14% Stock Analytics
DR REDDYS LABORATORIES ₹93,192.0 Cr -0.9% -10% -11.3% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

-0.7%

-6%

-12.9%

SENSEX

1.5%

-5.1%

0.6%


You may also like the below Video Courses